Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.
Savarino
Andrea
A
Cauda
Roberto
R
Cassone
Antonio
A
D000595:Amino Acid Sequence; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors* / Q000737:chemistry* / Q000378:metabolism; D001665:Binding Sites; D019295:Computational Biology; D016333:HIV Protease / Q000737:chemistry / Q000378:metabolism; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology*; D015800:Protozoan Proteins; D015203:Reproducibility of Results
D000962:Antimalarials; D017320:HIV Protease Inhibitors; D015800:Protozoan Proteins; D016282:Aspartic Acid Endopeptidases; D016333:HIV Protease; C100637:plasmepsin II